Regioselective Hydration of Alkynes
FULL PAPER
Compound 27: FeCl3 (97%, Aldrich, 85.0 mg, 10 mol%) and AgNTf2
(97%, Aldrich, 624.0 mg, 30 mol%) were placed in a 25 mL round-bot-
tomed flask, 1,4-dioxane (5 mL) was added and the mixture was magneti-
cally stirred at RT for 30 min. Compound 26 (430 mL, 2.6 mmol) and
water (140 mL, 7.8 mmol) were added and the mixture was placed in
a pre-heated oil bath at 808C and magnetically stirred for 18 h. After
cooling, n-hexane (60 mL) was added (precipitation of the catalyst was
observed) and the liquid was filtered under gravity. The filtrate was con-
centrated under reduced pressure and the resulting yellow oil residue
was purified by flash column chromatography on silica (hexane/EtOAc,
80:20). Fractions were concentrated under reduced pressure and, after
drying under vacuum, the resulting residue compound 27 (406 mg, 85%)
was obtained as a yellow oil. Rf =0.66 (20% EtOAc/hexane). GC-MS: m/
z (%): 200 (1) [M]+·, 164 (1), 138 (43), 123 (100), 107 (10); 1H NMR
(300 MHz, CDCl3): d=8.03–7.97 (m, 2H), 7.17–7.09 (m, 2H), 3.68 (t, J=
6.2 Hz, 2H), 3.15 (t, J=7.0 Hz, 2H), 2.22 ppm (tt, J=7.0, 6.2 Hz, 2H);
ed/Lewis co-catalysis seems to operate under these reaction
conditions. Nevertheless, a neat Brønsted catalysis after hy-
drolysis of the ironACHTUNGTRENNUNG(III) triflimide salt cannot be discarded.
Conclusion
The regioselective Markovnikov hydration of terminal and
internal aryl-alkyl alkynes is achieved by using iron(III) tri-
AHCTUNGTRENNUNG
flimide compounds in catalytic amounts. Hydrolysis of the
salt readily occurs to give catalytically active protons. Kinet-
ic experiments point to a possible Lewis/Brønsted co-cataly-
sis or even just a neat Brønsted catalysis. The use of triphe-
nylphosphane oxide allows the catalyst to be recycled. The
regioselective hydration in the benzylic position gives access
to a formal acylation of aromatic rings, and the synthesis of
Haloperidol and Melperone illustrates the potential use of
this synthetic protocol in organic synthesis.
13C NMR (300 MHz, CDCl3): d=197.3 (C=O), 166.1 (d, 1J
ACHTUNGTRENNUNG
254.7 Hz; C-F), 133.2 (d, 4J(C,F)=4.3 Hz; C), 130.6 (d, 3J
ACTHNUGTRENNUGN ACHTUNGTRENNNUG
2 ꢄCH), 115.9 (d, 2J
ACHTUNGTRENNUNG
26.7 ppm (CH2).
Haloperidol (24): Compound 27 (150 mg, 0.75 mmol), 4-(4-chlorophen-
yl)-4-hydroxypiperidine (321 mg, 1.5 mmol), and KI (2 mg, 1 mol%)
were placed in
a 10 mL cylindrical sealed vial. Anhydrous toluene
(2.5 mL) was added and the mixture was placed in a pre-heated oil bath
at 1258C and magnetically stirred for 25 h. After cooling, the reaction
mixture was washed with EtOAc (3ꢄ10 mL) and the liquid was filtered
under gravity. The filtrate was concentrated under reduced pressure and
the resulting brown oil residue was purified by flash column chromatog-
raphy on silica (EtOAc/MeOH/NH4OH, 95:5:1). Fractions were concen-
trated under reduced pressure and, after drying under vacuum, Haloperi-
dol 24 (168 mg, 60%) was obtained as a brown solid. Rf =0.6 (EtOAc/
MeOH/NH4OH, 95:5:1). GC-MS: m/z (%): 375 (1) [M]+·, 237 (98), 224
(100), 206 (26), 165 (8), 123 (16), 95 (7); 1H NMR (300 MHz, CDCl3):
d=8.03–7.95 (m, 2H), 7.41–7.35 (m, 2H), 7.32–7.26 (m, 2H), 7.17–7.08
(m, 2H), 3.53 (br s, OH), 3.01 (t, J=6.8 Hz, 2H), 2.97–2.88 (m, 2H),
2.67–2.55 (m, 4H), 2.20–2.07 (m, 2H), 2.06–1.98 (m, 2H), 1.77–1.67 ppm
(m, 2H); 13C NMR (300 MHz, CDCl3): d=198.0 (C=O), 164.0 (d, 1J-
Experimental Section
General methods: Reagents and solvents were obtained from commercial
sources (Aldrich) and were used without further purification otherwise
indicated. All the products obtained were characterised by GC-MS, 1H-
and 13C-NMR, and DEPT. When available, the characterisation given in
the literature was used for comparison. Gas chromatographic analyses
were performed in an instrument equipped with a 25 m capillary column
of 5% phenylmethylsilicone. GC/MS analyses were performed on a spec-
trometer equipped with the same column as the GC and operated under
1
the same conditions. H, 13C, DEPT and 19F were recorded in a 300 MHz
instrument using CDCl3 as solvent containing TMS as internal standard.
IR spectra of the compounds were recorded on a spectrophotometer by
impregnating the windows with a dichloromethane solution of the com-
pound and leaving to evaporate before analysis. Absorption spectra were
recorded on an UV/Vis spectrophotometer (UV0811M209, Varian) and
EPR experiments were carried out with a Bruker EMX/X equipment.
A
ACHTUNGERTN(NUNG C,F)=2.7 Hz; C), 132.9
AHCTUNGTRENNUNG
AHCTUNGTRENNUNG
(2 ꢄCH2-N), 37.6 (2 ꢄCH2), 36.0 (CH2), 21.0 ppm (CH2).
Melperone (25): Compound 27 (150 mg, 0.75 mmol), 4-methylpiperidine
(280 mL, 1.5 mmol) and KI (2 mg, 1 mol%) were placed in a 10 mL cylin-
drical sealed vial. Anhydrous toluene (2.5 mL) was added and the mix-
ture was placed in a pre-heated oil bath at 1258C and magnetically
stirred for 25 h. After cooling, the reaction mixture was washed with
EtOAc (3ꢄ10 mL) and the liquid was filtered under gravity. The filtrate
was concentrated under reduced pressure and the resulting brown oil res-
idue was purified by flash column chromatography on silica (EtOAc/
MeOH/NH4OH, 95:5:1). The fractions were concentrated under reduced
pressure and, after drying under vacuum, Melperone 25 (171 mg, 87%)
was obtained as a brown solid. Rf =0.5 (EtOAc/MeOH/NH4OH, 95:5:1).
GC-MS: m/z (%): 263 (1) [M]+·, 165 (4), 125 (54), 112 (100), 95 (9), 70
(6); 1H NMR (300 MHz, CDCl3): d=8.00–7.94 (m, 2H), 7.13–7.05 (m,
2H), 2.99–2.85 (m, 4H), 2.42 (t, J=7.3 Hz, 2H; CH2-CO), 2.02–1.88 (m,
4H), 1.64–1.53 (m, 2H), 1.42–1.27 (m, 1H), 1.26–1.13 (m, 2H), 0.88 ppm
(d, J=6.2 Hz, 3H); 13C NMR (300 MHz, CDCl3): d=198.3 (C=O), 165.5
Typical reaction procedure for acetophenone (2) (Table 3, entry 1): FeCl3
(97%, Aldrich, 8.0 mg, 10 mol%) and AgNTf2 (97%, Aldrich, 60.0 mg,
30 mol%) were placed in a 2 mL vial, and 1,4-dioxane (1 mL) was added.
The mixture was magnetically stirred at RT for 30 min, then phenylacety-
lene (56 mL, 0.5 mmol) and water (28 mL, 1.5 mmol) were added and the
mixture was placed in a pre-heated oil bath at 808C and magnetically
stirred for 20 h. After cooling, n-hexane (20 mL) was added (precipita-
tion of the catalyst was observed). The liquid was filtered under gravity
and the filtrate was concentrated under reduced pressure to give 2
(56 mg, 93%) as a yellow oil. GC-MS: m/z (%): 120 (40) [M]+·, 105
(100), 77 (40), 51 (40); 1H NMR (300 MHz, CDCl3): d=7.94–7.88 (m,
2H), 7.55–7.47 (m, 1H), 7.45–7.37 (m, 2H), 2.56 ppm (s, 3H).
Typical reaction procedure for reusing the OPPh3/[FeACTHNURTGNE(NUG NTf2)3] system
(Figure 4, A): FeCl3 (97%, Aldrich, 16.0 mg, 20 mol%), AgNTf2 (97%,
Aldrich, 120.0 mg, 60 mol%) and OPPh3 (55.6 mg, 40 mol%) were
placed in a 10 mL round-bottomed flask, then 1,4-dioxane (1.5 mL) was
added. The mixture was magnetically stirred at RT for 30 min, then phe-
nylacetylene (56 mL, 0.5 mmol) and water (28 mL, 1.5 mmol) were added
and the mixture was placed in a pre-heated oil bath at 1008C and mag-
netically stirred for 20 h. After cooling, n-hexane (20 mL) was added
(precipitation of the catalyst was observed). The liquid was decanted, the
remaining catalyst was washed with hexane, and the liquid was decanted
again. The combined organic phases were analyzed by GC. The catalyst
was dried for 4 h and used in a subsequent run.
(d, 1J
(C,F)=9.3 Hz; 2 ꢄCH), 115.5 (d, 2J
ACHTUNGTRENNUNG
N
(C,F)=3.3 Hz; C), 130.6 (d, 3J-
ACHTUNGTRENNUNG
U
N), 53.6 (2 ꢄCH2-N), 36.2 (CH2), 33.8 (2 ꢄCH2), 30.6 (CH), 21.7 (CH3),
21.4 ppm (CH2).
Acknowledgements
Synthesis of haloperidol (24) and melperone (25) from compound 26
(Scheme 2)
The work has been supported by Consolider-Ingenio 2010 (proyecto
MULTICAT), and PROMETEO from Generalitat Valenciana. J.R.C.A.
Chem. Eur. J. 2012, 00, 0 – 0
ꢂ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
&
7
&
ÞÞ
These are not the final page numbers!